Effects of the Jamison-Farabee consent decree: due process protection for involuntary psychiatric patients treated with psychoactive medication.
The Jamison-Farabee consent decree in California mandates an outside psychiatrist's review of involuntary medication of state hospital patients. Patients' rights advocates presumably hoped the decree would facilitate more frequent medication refusal, while clinicians predicted the procedure would impair patient care. Outside review led to only a 1.1% rate of medication denial; half of the patients involved deteriorated afterward. Examination of a sample of patients subject to the decree and two comparable samples 1 year and 10 years earlier suggests that patients' successful medication refusal was no more frequent after implementation of the decree and that the procedure had negligible effects on patient care or outcome for patients not denied medication.
D001291:Attitude of Health Personnel; D001294:Attitude to Health; D002140:California; D003134:Commitment of Persons with Psychiatric Disorders / Q000331:legislation & jurisprudence*; D006753:Hospital Records; D006801:Humans; D007872:Legal Guardians; D008505:Medical Staff, Hospital; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology; D028642:Persons with Psychiatric Disorders; D010043:Outcome and Process Assessment, Health Care; D010344:Patient Advocacy / Q000331:legislation & jurisprudence*; D010349:Patient Compliance; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D018570:Risk Assessment
D011619:Psychotropic Drugs